Chan's team discovered that EVs derived from nasopharyngeal carcinoma (NPC) cells exhibited high levels of ICAM-1 and CD44 variant 5 (CD44v5) expression. This evidence concerns the gene CD44 and nasopharyngeal carcinoma.